CALTERIDOL CALCIUM
Molecular Excipient
| Mwt. | LogP | HBD | HBA | PSA | RB | CSP3 |
|---|---|---|---|---|---|---|
| 404.0 | -2.2 | 4 | 8 | 145.0 | 8 | 0.82 |
- CAS
- 121915831
- UNII
- RPH56VWA1A
- SYNONYMS
-
- ZINC ID(s)
- Availability
- Present in 20 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has been an intervention in the following clincial trials (per clinicaltrials.gov).
| Code | Date | Title | Phase | Status |
|---|---|---|---|---|
| NCT01613417 | 2012-08-01 | Comparison of Prohance® With Gadovist®/Gadavist™ in Magnetic Resonance Imaging (MRI) of the Brain | Phase 4 | Completed |
| NCT00709852 | 2008-06-01 | Safety and Efficacy of Gadobutrol 1.0 Molar (Gadavist) in Patients for Central Nervous System (CNS) Imaging | Phase 3 | Completed |
| NCT00522951 | 2007-08-01 | SH L 562BB Phase II/III Dose Justification and Gadoteridol-controlled Comparative Study | Phase 3 | Completed |